Examples of this application include prostate [28], hepatocellular carcinoma [111], clear cell renal carcinoma [112] and oral squamous cell carcinoma [113], where the well-known miRNA is miR-21, which inhibits PTEN. The gene discussed is PTEN; the disease is hepatocellular carcinoma.